InvesT1D: Promoting Adolescent Investment in Diabetes Care - Trial NCT06384911
Access comprehensive clinical trial information for NCT06384911 through Pure Global AI's free database. This phase not specified trial is sponsored by Seattle Children's Hospital and is currently Not yet recruiting. The study focuses on Type 1 Diabetes. Target enrollment is 96 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Seattle Children's Hospital
Timeline & Enrollment
N/A
May 01, 2024
Feb 01, 2028
Primary Outcome
Time In Range
Summary
The goal of this clinical trial is to see if a financial incentives program called InvesT1D
 is helpful to support diabetes management in adolescents with type 1 diabetes.
 
 Adolescent participants will be randomized to usual care or receive financial incentives for
 meeting diabetes self-management and clinical outcomes goals during the study. Researchers
 will compare changes in glucose levels and person-reported outcomes between groups.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06384911
Non-Device Trial